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ABSTRACT
Identifying determinants of target specificity in two related bacterial peptide toxins
Andrew Holmes
Director: Keith Weaver Ph.D.

Toxin-antitoxin (TA) systems were originally identified as two-component
systems ensuring the stable inheritance of plasmids in bacterial populations. Recently,
they have been identified on bacterial chromosomes where their functions remain mostly
undefined. The par locus of E. faecalis plasmid pAD1 (parpAD1) was the first TA system
defined in a Gram-positive bacterium and a homolog encoded on the E. faecalis
chromosome (parEF0409) was later described. Related loci numbering in the hundreds
have been identified throughout Gram-positive bacteria based on homology to the toxin
of the system, Fst, and similarities in genetic organization and regulation. Despite their
similar sequences, over-expression of FstpAD1 and FstEF0409 have differing effects on the
host transcriptome, suggesting that sequence differences between the toxins are finetuned for distinct functions. Using a combination of domain swaps, as well as single and
double amino acid changes, we identified key amino acid residues between FstEF0409 and
FstpAD1 critical for triggering an FstpAD1-like response. This finding helps define the
critical region of toxin specificity and will aid in determining the mechanism of action of
this large family of peptide toxins.
Keywords: toxin-antitoxin systems, E. faecalis, plasmid pAD1, parEF0409
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CHAPTER 1
Introduction

Overview of Toxin-antitoxin Systems
Bacterial toxin-antitoxin (TA) systems are bipartite systems encoding a toxin that
inhibits cellular processes and an antitoxin that neutralizes the effects of the toxin. The
balance between toxin and antitoxin is essential; the antitoxin/toxin ratio must be high
enough for the antitoxin to neutralize the toxin effects. TA systems are widespread being
found in almost all phyla of bacteria and are conserved evolutionarily, suggesting that
they maintain a functional role in the bacterial cell (Akarsu et al., 2019; Fozo et al.,
2010). Additionally, TA systems can exist in a variety of genetic forms; they were first
discovered to be encoded within F and R1 plasmids, but they also have been more
recently identified on a multitude of different bacterial chromosomes such as locus
EF0409 in Enterococcus faecalis (E. faecalis) strain V583 (Ogura and Hiraga, 1983;
Gerdes et al., 1986; Weaver et al., 2009). The distribution of TA systems within bacteria
can possibly be attributed to their genetic transfer ability, horizontally and vertically, as
part of the bacterial mobilome--which is a group of mobile genetic elements (MGE) like
transposons, plasmids, phages and more (Guglielmini and Van Melderen, 2011).
Along with their prevalence in bacteria, TA systems are diverse in their molecular
mechanism and can be divided into groups based on their method of toxin-antitoxin
interaction. TA systems have been classified into six different types. The review by
Harms et al. (2018) discusses the four primary TA modules as determined by their
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respective antitoxin mechanism of inhibiting the toxin: both antitoxins of type I and type
III systems function via an RNA antitoxin that either blocks translation of the toxin
mRNA (type I) or by direct inhibition of the protein toxin (type III); the antitoxins in type
II and type IV are proteins that either inhibit toxin activity via binding the translated
protein directly (type II) or by negating the toxin protein’s effects in an indirect manner
(type IV). Type V TA systems have been recently characterized as a system where the
toxin is inhibited via a protein antitoxin that cleaves the toxin’s mRNA to prevent
translation (Wang et al., 2013). Aakre et al. (2013) describes type VI TA systems where
the antitoxin functions as an adaptor for a protease that disrupts the toxin’s function of
disrupting DNA replication via collapse of the replication fork. Research is continually
conducted on TA systems with increasing access to prokaryotic genomes, allowing for
future possibility to discover novel TA system characteristics. Even though these
systems differ in toxin regulation, bacterial species can also differ considerably in TA
module composition and number. For example, Escherichia coli (E. coli) K-12 MG1655
encodes for 35 known TA systems comprised of 19 type I loci, 12 type II loci, and three
type IV loci whereas Staphylococcus aureus has 5 identified TA systems constituted of
two type I loci and three type II loci, although several TA modules resembling type III
loci have been detected (Harms et al., 2018; Schuster and Bertram, 2016).
Bacterial TA systems have been accurately identified in a variety of hosts,
although their biological functions are not as well-determined--especially when the
system is encoded chromosomally. Nonetheless, plasmid TA modules are well
understood as operons that encode for post-segregational killing (PSK) mechanisms, also
known as addiction modules. TA systems that are involved in PSK operate via a
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differential stability of the toxin and antitoxin; in daughter bacterial cells that fail to
inherit the plasmid, the antitoxin quickly degrades and the toxin exerts its effects of
inhibiting cellular processes and/or killing the cell (Gerdes et al., 1986; Unterholzner et
al., 2013). The hok/sok system of plasmid R1 and ccdAB of plasmid F are two wellstudied examples of PSK functions performed by TA modules (Gerdes et al., 1986;
Ogura and Hiraga, 1983). Interestingly, the hok/sok module is a type I system and the
ccdAB is a type II system, thus the PSK function is not bound to a certain TA-system
type. A similar genetic stabilization function of TA systems is as a mediator of
superintegrons, which are assemblies of genes each bordered by recombinational
elements (Szekeres et al., 2007). The study by Szekeres et al. (2007) demonstrated that
superintegrons and genomic dispensable regions of E. coli exhibited large-scale genome
loss when lacking TA loci, and that incorporation of TA systems into these environments
helped reduce gene loss.
TA systems have more functions than just stabilization of genetic elements, as
they have been shown to be involved with bacterial immunity processes. Both
chromosome and plasmid TA systems have been theorized to function in abortive
infection mechanisms, an immunity process whereby a bacteriophage-infected bacterial
cell performs suicide that ultimately helps protect bacterial populations against infections
of invasive genetic elements (Unterholzner et al., 2013; Harms et al., 2018). For
example, the chromosomal TA systems of toxIN and tenpIN families have been shown to
interfere with bacteriophage infection of bacteria; the chromosomal mazE/mazF TA
module invoked cell death via abortive infection when exposed to P1 bacteriophage
(Goeders et al., 2016; Hazan and Engelberg-Kulka, 2004). Suicide of infected bacterial
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cells is an altruistic mechanism that allows for decreased bacteriophage genetic
replication.
Bacterial TA systems have also been demonstrated to serve a role in bacterial
persistence, specifically, subpopulations of cells that are tolerant to environmental
stressors like lack of nutritional resources, antibiotics and other toxic chemicals (Harms
et al., 2018). This phenotypic persistence is accomplished via a conversion of the
bacterial cell to a dormant state where it inactivates cellular processes that are affected by
the stress condition (Harms et al., 2016). Large amounts of evidence exist for TA
modules role in bacterial persisters: overproduction of the MqsR toxin in E. coli increases
persister cell formation and the converse decrease in persisters occurs with deletion of the
MqsR locus (Kim and Wood, 2010); a deletion of the tisAB/istR TA locus resulted in a
significant decrease in persister cells tolerant to the antibiotic ciprofloxacin (Dörr et al.,
2010); deletion of the hipBA TA module caused a decrease in persister cells in biofilm
and stationary phase populations (Keren, 2004).
The various physiological functions of TA systems have been tied to various
bacterial pathogens important in clinical settings, particularly to those of the ESKAPE
group (Fernández-García et al., 2016). Rice (2008) details the following pathogens in
ESKAPE: Enterococcus faecium (E. faecium), Staphylococcus aureus, Klebsiella
pneumoniae (K. pneumoniae), Acinetobacter baumanni, Pseudomonas aeruginosa, and
Enterobacter species. This group, alongside other pathogens like E. faecalis, are the
primary causers of hospital infections, and they are becoming increasingly resistant to
antimicrobial agents (Rice, 2008; Fernández-García et al., 2016). K. pneumoniae can
cause nosocomial pneumonia and intra-abdominal infections and has hundreds of
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associated type II TA loci (Fernández-García et al., 2016). The RelBE TA system is one
example of a TA module relating to pathogenesis within K. pneumoniae as it has
associated with persister cells tolerant of antibiotics like β-lactams, quinolones and
aminoglycosides (Tashiro et al., 2012). E. faecium and E. faecalis can cause infections
of the urinary tract infections, hospital bacteremia, and surgical wounds. Regarding TA
systems, these enterococci species have multiple TA systems relating to stable plasmid
maintenance and inheritance relating to antibiotic resistance (Fernández-García et al.,
2016). Fernández-García et al. (2016) detailed a high prevalence of TA operons in
vancomycin-resistant Enterococcus isolates relative to isolates sensitive to the antibiotic.

Fst and Fst-like Toxins
The Fst toxin encoded by the enterococcal plasmid pAD1 TA system (parpAD1) is
a type I TA module and was the first type I system to be described in a gram-positive
bacterium (Weaver et al., 1996). Moreover, the plasmid parpAD1 locus in Enterococcus
faecalis is one of the only known RNA-regulated PSK system in gram-positive bacteria
(Patel and Weaver, 2006). The entire parpAD1 locus spans less than 400 nucleotide base
pairs and is transcribed convergently to yield two interacting RNAs--RNA IpAD1 and
RNA IIpAD1 (Weaver et al., 1996). The antitoxin RNA IIpAD1 binds the toxin RNA IpAD1
in a manner that suppresses the translation of the RNA IpAD1 encoded toxin FstpAD1
(Greenfield et al., 2000; Patel and Weaver, 2006). The two RNAs are shown in Figure 1
where interaction initiates at the U-turn motif (green region with the labeled arrow A) and
then interaction proceeds to the direct repeat sequences DRa and DRb (pink and blue
regions with the labeled arrows B respectively) according to Weaver (2012). RNA-RNA
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interactions at DRa and DRb sequester the initiation codon (I.C.) thereby preventing
translation.

Figure 1. Interacting secondary structures of RNA IpAD1 and RNA IIpAD1. Adapted from
“The par toxin-antitoxin system from Enterococcus faecalis plasmid pAD1 and its
chromosomal homologs,” by K. Weaver, 2012, RNA Biology, 9(12), 1498-1503. Adapted
with permission.

Additionally, RNA IpAD1 has intramolecular structures critical in regulation of parpAD1
Specifically, the 5’ stem-loop (5’-SL) structure of RNA IpAD1 (depicted in Figure 1 by the
blue box) modulates translation and ribosome binding by sequestering the FstpAD1 ShineDalgarno sequence (Greenfield et al., 2000; Weaver, 2012). The 5’ upstream helix of
RNA IpAD1 (depicted in figure 1 by the red box labeled 5’-UH) helps provide the greater
stability of RNA IpAD1 relative to RNA IIpAD1 by sequestering 5’ nucleotides from cellular
RNase degradation (Shokeen et al., 2008; Weaver, 2012; Greenfield et al., 2000). The
lesser stability and selective degradation of antitoxin RNA IIpAD1 allows for translation of
RNA IpAD1 to Fst toxin upon plasmid loss (Greenfield et al., 2000). After translation, the
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proteic FstpAD1 is theorized to insert into the plasma membrane via an ɑ-helix around
amino acid residue 4 and exit around amino acid residue 26 with an unstructured, charged
tail at the carboxyl-terminus (Göbl et al., 2010).
Although FstpAD1 is most likely localized and active in the membrane,
overexpression of this toxin can have several primary effects: condensation of the
nucleoid, unequal chromosome segregation between daughter cells, and issues with cell
division/peptidoglycan synthesis characterized by cellular elongation, altered septal
placement, and hyperseptation (Patel and Weaver, 2006; Weaver 2012). FstpAD1 also
increases membrane permeability, although this was found to be a secondary effect by
Patel and Weaver (2006). The specific target(s) of FstpAD1 is still unknown, but evidence
suggests an intracellular target since the external application of synthetic FstpAD1 has no
cellular effect (Weaver et al., 2003). Despite limited information on the true target(s) of
FstpAD1, the amino acid residues essential for the toxic effects have been defined.
Mutagenic analysis by Weaver et al. (2009) found that the predicted transmembrane
domain was the most essential component for toxicity.
The toxin of the parpAD1 locus has a homologous putative toxin, FstEF0409, that is
encoded by the parEF0409 locus found on the E. faecalis chromosome (Ibrahim et al.,
2007; Weaver et al., 2009). Although FstEF0409 has similar features to other toxins within
the par family, its biological function and physiological mechanisms are not as well
understood as FstpAD1. The parEF0409 TA system is hypothesized to modulate sugar
transport because its locus is nestled between two paralogous mannitol family
phosphotransferase system gene sets (Weaver et al., 2017; Weaver, 2012). A function as
a PSK system is unlikely as this TA system has not been associated with any MGE that
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would indicate an addictive behavior (Weaver et al., 2017). Additionally, the parEF0409
locus has conserved structural features of the parpAD1 locus—such as converging
promotors, a stabilizing 5’-UH, a stem loop structure, direct repeats that provide RNA
interacting sequences amongst other features (Weaver et al., 2009). Despite these
similarities, data from Weaver et al. (2017) demonstrates that parEF0409 and parpAD1 can
exist together and not interfere with the others function. The differences between the
interacting regions of RNA molecules was theorized to allow for coexistence (Weaver et
al., 2017). Moreover, Weaver et al. (2017) suggested that the plasmid pAD1 TA system
may have evolved to bypass chromosomal TA systems like that of parEF0409.
Besides the two related parpAD1 and parEF0409 TA modules, Weaver et al. (2009)
identified seven further FstpAD1-like systems and Kwong et al. (2010) discovered more
than 200 additional modules that code for Fst-like toxins through the utilization of
homology searches and the NCBI nucleotide sequence database. Overall, this par family
of Fst-like toxins were identified in numerous gram-positive bacterial species and were
found to be encoded by chromosomal, plasmid, and phagic genetic elements (Kwong et
al., 2010). The most prominent commonality amongst all of the Fst-like toxins is the
characteristically short polypeptide length, ranging between 27 to 35 residues (Kwong et
al., 2010). Similar to the results from the earlier study by Weaver et al. (2009), these Fstlike toxins were predicted to have a hydrophobic transmembrane domain (Kwong et al.,
2010).
Analysis of the peptide sequences of the Fst-like toxins also yielded
characteristics that apply to most, if not all, of the toxins (Weaver et al., 2009; Kwong et
al., 2010). Kwong et al., found that all Fst-like toxins exhibited similar expression
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sequences, containing both the mRNA toxin and an antisense RNA antitoxin (2010).
Furthermore, the DNA sequence analysis indicated that all loci possess a potential
promoter with transcriptional machinery resembling the σ70 factor, in addition to a
bidirectional terminator sequence close to the culmination of the toxin expression
sequence similar to the prototypical parpAD1 locus as shown in Figure 2(a) (Kwong et al.,
2010). The duplex terminator of these toxins yields a stable, complementary SL structure
similar to one shown in Figure 1 (Kwong et al., 2010; Greenfield et al., 2000). Previous
work done by Greenfield et al. (2001) has shown that the resulting SL structures are
crucial for inhibiting the Fst toxin in the original FstpAD1 system; therefore, these loop
interactions may also be important for the negation of their corresponding toxins for the
rest of the familial Fst-like toxins. Additionally, complementary regions of direct repeats
(DRa and DRb) were readily distinguishable in these toxins (Kwong et al., 2010). The
direct repeats can be visualized in Figure 2(a) where they overlap the start codons and are
near the bidirectional terminator (Kwong et al., 2010). Furthermore, these related toxins
contained sequences for the 5’ stem-loop (5’-SL) and 5’ upstream-helix (5’-UH) of RNA
I as shown in Figure 2(b), providing further evidence of a possible shared regulatory
mechanism as the prototypical parpAD1 locus (Kwong et al., 2010). Both Kwong et al.
(2010) and Weaver et al. (2009) hypothesized that although these features were highly
conserved, the great variability in their DNA sequence, particularly in the regions
encoding RNA-RNA interaction sites, would suggest that the TA systems would exhibit
specificity in their targets.
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Figure 2. Structural features conserved within Fst-encoding par-like loci. Figure 2(a)
represents the organization of parpAD1 and 2(b) demonstrates the conserved features of
Fst toxins within par-like loci. Adapted from “Identification and characterization of a
family of toxin-antitoxin systems related to the Enterococcus faecalis plasmid pAD1 par
addiction module,” by K. Weaver, 2009, Microbiology, 155(Pt 9), 2930-2940. Adapted
with permission.

A recent study done by Weaver et al. (2017) found that the two similar Fst toxins,
FstpAD1 and FstEF0409 had both shared and unique effects on the transcriptome of their
native host, E. faecalis. The two related Fst toxins predominately affected genes
encoding for surface proteins (Weaver et al., 2017). Their analysis suggested that the two
toxins have a shared effect on plasma membrane organization while still having the
capability to exert their function on distinct targets within the cell, although no clear
interactional mechanism was proposed other than their differing amino acid composition.
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To investigate the underlying mechanism that causes different gene expression in
response to the two toxins, various mutants of FstpAD1 and FstEF0409 were constructed.
These toxins utilized the pheromone-responsive plasmid vector, designated as pCIE,
which ultimately allowed the movement of the mutant toxin from E. coli to E. faecalis
(Weaver et al., 2017). Vector pCIE allowed for tight regulation of the toxin constructs in
response to nanogram amounts of cCF10 pheromone (Weaver et al., 2017). After
introduction into E. faecalis, these mutants were assessed and compared for expression of
multiple genes when induced with ccf10 pheromone to determine which amino acid
residue substitutions were responsible for creating the distinct transcriptomic effects seen
between the two related bacterial toxins.
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CHAPTER 2
Materials and Methods

Bacterial Strains, Media, and Growth Conditions
All bacterial strains used in this study are shown in Table 1. All constructs of
mutant Fst toxin and primers are shown in Table 2. All E. faecalis cultures (OG1RF) for
growth curves and RNA preparation were grown in M9YEG medium that consists of
96% M9 Base (M9 Salts, casamino acids, and yeast extract), 1% 0.1M magnesium sulfate
(MgSO4), 1% 0.01M calcium chloride (CaCl2), and 2% 1.0M glucose. Cultures were
grown overnight and diluted to one to two percent into new M9YEG medium and were
grown with the antibiotic chloramphenicol (Sigma-Aldrich) if necessary, to ensure
plasmid selection. All E. faecalis cultures for plasmid electroporation experiments were
grown in Todd Hewitt Broth made of 30g of Todd Hewitt powder (Sigma-Aldrich) per
one liter of distilled water. Luria-Bertani (LB) medium was used for all E. coli growth
with the following formulation per one liter: 10g peptone, 5g yeast extract, and 5g
sodium chloride (NaCl). The antibiotic concentration of chloramphenicol routinely used
was either 10µg/mL (Cm-10) or 25µg/mL (Cm-25) for culture growth when plasmid
selection of pCIE was desired. The antibiotic ampicillin (amp) was also used at a
concentration of 100µg/mL. All liquid cultures were grown at 37°C with rotary shaking
at either 25rpm for E. faecalis or 250 rpm for E. coli. Any growth on solid medium
utilized the respective concentrations with the addition of 17g Agar (Research Products
International) per one liter of medium.
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Strain or plasmid
Strains
DH5⍺
OG1RF
Plasmid
pCIE

Relevant phenotype
E. coli intermediate host for cloning
E. faecalis used for all testing

Cm-resistant E. coli - E. faecalis shuttle expression vector with
cCF10-regulateable promoter prgQ

Table 1. Bacterial strains and plasmid used in this study
The peptide pheromone cCF10 (H-LVTLVFV-OH) used previously in Weaver et
al. (2017) was dissolved in dimethylformamide and stored at -20°C. For experiments that
involved induction with pheromone, cultures were grown overnight in M9YEG-Cm25 for
optimal plasmid pCIE construct retention. Overnight cultures would then be diluted at 1
to 2% in M9YEG-Cm10 and grown for 1 hour prior to cCF10 pheromone addition.
Pheromone cCF10 was used at multiple working concentrations to assess phenotypic
toxicity of strains: 0ng/mL, 1ng/mL, 5ng/mL, 10ng/mL, or 50ng/mL. Strains with
0ng/mL induction experiments had an equivalent volume of dimethylformamide added.

Plasmid Construction, DNA Purification and Manipulation
Mutant constructs encoding varying FstpAD1 and FstEF0409 derivatives as shown in
Table 2 were commercially synthesized and delivered in plasmid pUCminusMCS (Blue
Heron Biotech, LLC). The mutant toxin alleles within the pUCminusMCS vector and the
pCIE expression vector contained flanking BamHI and SphI restriction enzyme sites.
Mutant toxins were cut from pUCminusMCS and cloned into plasmid pCIE through
restriction digest and ligation products purchased through New England BioLabs or
Promega according to provided protocols. A post-ligation cut was performed with SalI
13

(New England BioLabs) that eliminated any pCIE plasmid without the necessary cloned
construct. Mutant toxin-containing pCIE plasmids were transformed into competent E.
coli DH5ɑ cells per manufacturer instructions (Invitrogen) and spread onto LB-cm25
plates. Bacterial colonies were then selected and tested for ampicillin resistance by
picking colonies onto LB-Amp plates to ensure the absence of pUCminusMCS. Plasmid
purification from DH5ɑ colonies with the desired plasmid mutants was performed
through using the Quantum Prep plasmid miniprep kit (Qiagen) according to their
instructions. Mutant inserts were tested for proper base pair length via restriction enzyme
digests and agarose gel electrophoresis. Mutant pCIE plasmids were inserted into E.
faecalis cells through electroporation of plasmids into OG1RF cells treated with
lysozyme as described by Cruz-Rodz and Gilmore (1990) and electroporation conditions
described by Brinkman et al. (2012). To assess if the proper mutations were emplaced,
plasmids were isolated from the plasmid containing OG1RF cells via a modified
Quantum Prep plasmid miniprep kit protocol. ON cultures were diluted 50% into new
M9YEG media containing 3% glycine and were grown for 90 minutes. Cultures were
pelleted, washed in water, and again pelleted. Pellets were resuspended in 25% sucrose
containing lysozyme at a 30mg/mL concentration and incubated until a slight separation
was seen between a clear supernatant and cells. Samples were then pelleted and run
through the Quantum Prep plasmid miniprep kit. Constructs were again tested for correct
size inserts via restriction enzyme digests and agarose gel electrophoresis. Plasmids that
contained the proper insert size were then sequenced by Eurofins Genomics LLC to
determine correct DNA sequence of the emplaced mutant toxins.
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Mutant Fst toxin or Primer
Mutant Fst Toxin
pAD1 wild-type
pAD1 E19K
pAD1 L7K-E19K
pAD1EF0409
pAD1ter2
pAD1ter5
EF0409 wild-type
EF0409 K19E
EF0409pAD1N6-K19E
EF0409 K7L-K19E
EF0409pAD1
EF0409pAD1:13
EF0409pAD1:14
EF0409ter2
EF0409ter5

Sequence
Amino Acids
VKDLMSLVIAPIFVGLVLEMISRVLDEEDDSRK
VKDLMSLVIAPIFVGLVLKMISRVLDEEDDSRK
VKDLMSKVIAPIFVGLVLKMISRVLDEEDDSRK
VKDLMSLVIAPIFVGLVLEMISRVLEKQNEE

Primer
pCIE-EF0409 FWD
pCIE-EF0409 REV
10493 FWD
10493 REV
10301 FWD
10301 REV
MgtA FWD
MgtA REV
CelA3 FWD
CelA3 REV
GyrB FWD
GyrB REV

Nucleotides
GTATACAGTTCATGTATATGTTCCC
TGTGATGCACCTCCTTTC
CAGATGACGGCTCAATTCAAAC
CAGCGGTACTTCCTTCAATCA
GCACGATGTCTGGTGATGAT
CTTCGCTCCTAAATCCGCTAAG
AAAGGTGCGGTTGAAGAAATG
TGACGCAGTGTCTCTGTTAAG
AGAAGATCGTGGCATGGAAG
TGAAACGAACTTGTGGACCTAA
ACCAACACCGTGCAAGCC
CAAGCCAAAACAGGTCGCC

VKDLMSLVIAPIFVGLVLEMISRVLDEEDDS
VKDLMSLVIAPIFVGLVLEMISRVLDEE
MYEIVTKILVPIFVGIVLKLVTIWLEKQNEE
MYEIVTKILVPIFVGIVLELVTIWLEKQNEE
MKDLMSLILVPIFVGIVLELVTIWLEKQNEE
MYEIVTLILVPIFVGIVLELVTIWLEKQNEE
MYEIVTKILVPIFVGIVLKLVTIWLDEEDDSRK
MYEIVTKILVPIFVGIVLKMISRVLDEEDDSRK
MYEIVTKILVPIFVGIVLEMISRVLDEEDDSRK
MYEIVTKILVPIFVGIVLKLVTIWLEKQN
MYEIVTKILVPIFVGIVLKLVTIWLE

Table 2. Mutant Fst toxins with encoded amino acid residue sequence All amino acid
sequences are shown from the amino-terminus to carboxyl-terminus with the bolded
residues indicating a mutation. Primers are listed from the 5’ to 3’ end.
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RNA Purification and Manipulation
For any incubation period, E. faecalis cultures were grown at 37°C and 25rpm.
Cultures were grown overnight in M9YEG-Cm25 and then inoculated in fresh M9YEGCm10 at a 2% dilution. These cultures were then grown for 1 hour before being induced
with cCF10 at 1ng/mL or 5ng/mL; uninduced samples were given 5µL of
dimethylformamide. After induction, cultures were grown for one more hour before
harvesting. Cultures were harvested by centrifuging, resuspending the bacterial pellets in
M9 Base and Bacteria RNA Protect (Qiagen), incubating for 5 minutes at room
temperature, centrifuging, and then freezing the pellets at -80°C.
For RNA preparation, pellets were thawed, resuspended in 200µL of Tris/EDTAmutanolysin-lysozyme solution (10mM Tirs [pH 8.0], 1.0mM EDTA [pH 8.0],
mutanolysin [500 units/mL], lysozyme [30mg/mL]), and incubated for 10 minutes at
37°C in a water bath. 700µL of Buffer RLT/β-mercaptoethanol (1mL Buffer RLT
[Qiagen RNeasy minikit] with 10µL β-mercaptoethanol) was added to each resuspension
and vortexed to mix. RNA purification was then performed with the Qiagen RNeasy
minikit per the provided instructions within the kit. All the RNA from each sample was
incubated with 2µL of TURBO DNase and 10µL of TURBO DNase Buffer
(Ambion/Thermo Scientific) at 37°C for 30 minutes; an additional 1µL of TURBO
DNase was added and the samples were incubated for 30 more minutes at the same
temperature. The DNase enzyme was removed through the RNA Clean & Concentrator25 (Zymo Research) according to their provided protocol. 1µg of RNA was then mixed
with 1 µL of Random Primer 9 (New England BioLabs), 1 µL of 10mM dNTP Mix (New
England BioLabs), and a corresponding amount of DEPC-treated water to achieve a total
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14 µL mixture, before being incubated at 65°C for 5 minutes. Reverse transcription was
performed with SuperScript III Reverse Transcriptase (ThermoFisher Scientific) per the
manufacturer’s instructions. The reversely transcribed samples were diluted 10-fold by
the addition of water and then were stored at -80°C. 5 µL of cDNA samples were mixed
with specific forward and reverse primers listed in Table 2 and with PerfeCTa SYBR
Green SuperMix (Quanta-Bio) to a final 25µL qPCR total mixture in 96-well Thermo
Scientific PCR Plates. qPCR was performed on sample triplicates and measured through
an ABI 7300 system (Applied Biosystems [Life Technologies]) using the standard
amplification cycle with a melting-curve analysis. cDNA results were compared to a
standard curve created against purified OG1RF genomic DNA and the relevant primers
for each gene of interest. The final Ct results of the RT-qPCR samples were corrected for
efficiency through standard curves with r2 values above 0.99. The Ct values utilized the
standard curves to generate estimated ng amounts of cDNA, and these were normalized
using the ratio of the average nanogram cDNA amounts of the desired gene to the
average nanogram cDNA amounts of gyrB, a housekeeping gene specific for E. faecalis.
Each sample had at least three biological replicates.
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CHAPTER 3
Results

Determinants of target specificity between the two toxins were assessed through
qRT-PCR of induced mutant samples at pheromone concentrations of 0ng/mL, 1ng/mL,
and 5ng/mL. The amino acid sequence of constructed Fst mutants is shown in Table 2
for reference. Multiple genes of E. faecalis were utilized to examine and compare the
critical domains of the toxins: (1) 10493 (OG1RF_RS02610 in the study done by Weaver
et al. [2017]) which is theorized to encode a copper P-type ATPase transport and showed
the largest difference between FstpAD1 and FstEF0409; (2) 10301 (OG1RF_RS01655) which
is theorized to encode for an ATP binding cassette (ABC) transporter and is linked to
parEF0409 (3) MgtA (OG1RF_RS12145) which is theorized to encode for a P-type ATPase
that imports magnesium ions and exhibits an induction response for both toxins; and (4)
CelA3 (OG1RF_10750) which is theorized to encode a phosphotransferase system
involved in sugar transport and exhibits a repression response for both toxins. The wildtype FstEF0409 and FstpAD1 toxins exhibited a graded response to cCF10 pheromone for all
assessed genes as shown in Figure 3. These two wild-type toxins had similar effects on
10301, MgtA, and CelA3. However, there was a significant difference in 10493 induction
between the two toxins at a 5ng/mL cCF10 concentration that was also seen by Weaver et
al. (2017).
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Wild-type Fst Toxins MgtA
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Figure 3. FstpAD1 and FstEF0409 wild-type toxins on selected genes. Black bars indicate
FstpAD1 and white bars indicate FstEF0409. Error bars represent 95% confidence intervals.

To identify the determinants of the specificity between FstpAD1 and FstEF0409,
mutated Fst toxins of each were constructed and are shown in Table 2. These toxins’
effects on 10493 expression are exhibited in Table 3. A loss of FstpAD1 function was
observed when any amino acid(s) swap was made or when a truncation was made at the
C-terminus. However, incorporating one or two amino acids from FstpAD1 into the
corresponding positions of FstEF0409 residues (EF0409 K19E and EF0409 K7L-K19E
respectively) demonstrated a gain-of-function resembling FstpAD1. Clearly, the leucine
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residue at position 7 and the glutamic acid residue at position 19 in FstpAD1 are important
for this toxins specificity in inducing 10493.

Fst Sample

ng cDNA (avg.)

Standard deviation Significance

pAD1

8.983

1.221

pAD1 E19K

2.360

1.888

*

pAD1 L7K-E19K

0.075

0.015

*

pAD1EF0409

0.149

0.057

pAD1ter2

3.525

0.619

*

pAD1ter5

0.195

0.062

*

EF0409

0.253

0.151

EF0409 K19E

1.933

0.341

*§

EF0409 K7L-K19E

3.779

1.505

*§

EF0409pAD1

0.186

0.059

EF0409pAD1:13

0.502

0.240

EF0409pAD1:14

2.162

0.439

EF0409ter2

0.104

0.030

EF0409ter5

0.039

0.004

*§
*

Table 3. Fst toxins expression of 10493 when induced with 5ng/mL cCF10. The symbol
“*” next to a sample indicates a significant difference compared to their respective wildtype Fst toxin. The symbol “§” next to a sample indicates toxins that demonstrated an
FstpAD1-like gain of function.

The amino acid swap mutations did not have any induction effects on the other assessed
genes. However, FstpAD1 has other amino acid residues that are essential for triggering
the induction of 10493. The truncated FstpAD1 toxins, pAD1ter2 and pAD1ter5, exhibit
significant decreases in 10493 expression with their lack of residues at the carboxylterminus as shown in Figure 4. Although important, more than just the carboxylterminus tail of FstpAD1 is necessitated for triggering induction of 10493 as shown by the
failure of EF0409pAD1 in Table 3. For the EF0409pAD1 hybrid, it is probable that
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addition of the leucine and glutamic acid residues at positions 7 and 19 respectively may
have conferred a nearly full FstpAD1-like response of 10493.
A commonality amongst all genes assessed was the importance of the carboxylterminus tails of both FstEF0409 and FstpAD1. The truncated FstEF0409 and FstpAD1 toxins
resulted in a decreased response of induction or repression for all genes. With these
truncated toxins, genes 10493, MgtA (as shown in Figure 5), and 10301 exhibited
decreased induction at 5ng/mL cCF10 pheromone whereas gene CelA3 demonstrated less
repression when compared to the wild-type Fst toxins (data not shown).
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ng cDNA
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0
pAD1

pAD1ter2

pAD1ter5

ng cDNA

Figure 4. FstpAD1 and truncated FstpAD1 toxins expression of 10493 when induced with
5ng/mL cCF10 pheromone.
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EF0409

EF0409ter2

EF0409ter5

Figure 5. FstpAD1 and FstEF0409 and truncated toxins expression of MgtA when induced
with 5ng/mL cCF10 pheromone.
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CHAPTER 4
Discussion and Conclusions

Substantial evidence exists for the physiological roles of TA systems in
bacteria—such as addiction modules that stabilizes inheritance of MGE on chromosomes
and plasmids, abortive infection mechanisms to prevent infection of foreign phagic
elements, and as mediators of persister cell formation that may provide tolerance to
antimicrobial agents. A multitude of TA systems have been inextricably linked to
pathogenic properties in certain nosocomial bacteria like the ESKAPE group and E.
faecalis that cause most hospital infections, ultimately warranting investigation of their
properties and roles to combat infection. Moreover, multidrug resistant nosocomial
bacteria are increasingly becoming prevalent, so TA systems may present a unique target
that can be exploited for the treatment of infections. Future research is necessitated to
better characterize TA systems and their diverse function(s), genetic organization, and
antitoxin regulation mechanisms, amongst other pertinent aspects of TA morphology.
The parpAD1 TA system was the first type I module described in the gram-positive
bacterium E. faecalis. The parpAD1 locus stabilizes its host plasmid, pAD1, by a PSK
mechanism dependent upon the relatively small FstpAD1 peptide toxin that localizes within
the cytoplasmic membrane. Expression of FstpAD1 has been shown to condense nucleoid
structures, cause unequal segregation of chromosomes in replicating cells, and affect cell
division at the septum by impacting peptidoglycan synthesis (Patel and Weaver, 2006;
Weaver 2012). Further investigations of Fst-like toxins by Kwong et al (2010) and
Weaver et al (2009) identified over two hundred Fst-like toxins that share locus
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organization and secondary structure features between the interacting RNA toxins.
Despite structural conservation within the par family, toxins exhibit both general and
specific interactions with their target(s) as indicated by the respective shared and variant
gene expression response to overexpression of FstpAD1 and FstEF0409. The unshared levels
of specific gene induction between FstEF0409 and FstpAD1 demonstrates the existence of
determinant regions of each toxin critical for triggering their unique response.
Through the utilization of a pheromone-responsive expression vector, the data
presented here demonstrates the determinants of FstpAD1 and FstEF0409 toxicity function.
The carboxyl-terminal tail for both toxins was determined to be important for responses
in all genes assessed, regardless of whether the gene was induced or repressed due to
toxin overexpression. However, the carboxyl-terminal tails do not explain the distinct
effects of FstpAD1 and FstEF0409 on targets related to expression of 10493. The hybrid
toxins EF0409pAD1:13 and EF0409pAD1:14 produced significant differences in
induction of 10493 and only deferred by one amino acid at position 19. These results
provoked the idea to swap the FstEf0409 lysine for the FstpAD1 glutamic acid at position 19.
Incorporating the corresponding FstpAD1 amino acid residue at position 19 instead of the
normal residue of FstEF0409 resulted in a partial FstpAD1-like response of 10493.
Furthermore, pairing the position 19 swap with the incorporation of another FstpAD1
position 7 amino acid reside in FstEF0409 generated an even greater response akin to the
effect of FstpAD1 on 10493. Therefore, the amino acid residues at positions 7 and 19 in
FstpAD1 are important for triggering the distinct expression of its 10493 target.
In summary, determinants of the critical regions of toxins FstpAD1 and FstEF0409
were identified to be key amino acid residues and the carboxy-terminus tail. Both toxins
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exhibit a shared need for the carboxyl-terminus tail for certain intracellular targets,
demonstrating a generalized mode of interaction. Specificity of targets between FstpAD1
and its chromosomal homologue FstEF0409 is dictated by the variant amino acid residue
sequence, especially at residue positions 7 and 19. One possible explanation is that the
negatively charged glutamic acid residue at position 19 of FstpAD1 has repulsive
electrostatic interactions with the negatively charged phospholipid head of the plasma
membrane. In theory, this would allow for greater mobility of FstpAD1 to interact with
targets relating to 10493. Moreover, the glutamic acid residue at position 19 of FstpAD1
may facilitate an electrostatic interaction with proteins or other targets that are associated
with 10493. The oppositely charged lysine residues at positions 7 and 19 of FstEf0409
perhaps create a lysine clamp with the negatively charged phospholipid head groups of
the membrane, ultimately hindering or restricting the movement of FstEF0409. In addition,
the positive charge of the lysine residue at position 19 in FstEF0409 may repel certain
protein targets, thus also creating specificity. Future experiments will need to be
conducted to tease out the nature of these interactions. These results help elucidate the
fine-tuned responses of these toxins and suggest that other Fst-related toxins have similar
specific targets determined by their peptide sequence. Encouraging future investigations
of Fst-like toxin specificity will be useful for further understanding how this related
family of toxins interact with their targets and their physiological function.

24

REFERENCES

Aakre, C. D., Phung, T. N., Huang, D., & Laub, M. T. (2013). A bacterial toxin inhibits
DNA replication elongation through a direct interaction with the β sliding clamp.
Molecular cell, 52(5), 617–628. https://doi.org/10.1016/j.molcel.2013.10.014
Akarsu, H., Bordes, P., Moise Mansour, D. B., Genevaux, P., & Falquet, L. (2019).
TASmania: A bacterial Toxin-Antitoxin Systems database. Retrieved from
https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006946
Brinkman, C. L., Bumgarner, R., Kittichotirat, W., Dunman, P. M., Kuechenmeister, L.
J., & Weaver, K. E. (2012). Characterization of the Effects of an rpoC Mutation
That Confers Resistance to the Fst Peptide Toxin-Antitoxin System Toxin.
Journal of Bacteriology, 195(1), 156-166. doi:10.1128/jb.01597-12
Cruz-Rodz AL, Gilmore MS. 1990. High efficiency introduction of plasmid DNA into
glycine treated Enterococcus faecalis by electroporation. Mol Gen Genet
224:152–154. https://doi.org/10.1007/BF00259462.
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